ClinVar Miner

Submissions for variant NM_014363.6(SACS):c.8393C>A (p.Pro2798Gln) (rs140551762)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Athena Diagnostics Inc RCV000513770 SCV000614988 uncertain significance not provided 2018-03-20 criteria provided, single submitter clinical testing
CeGaT Praxis fuer Humangenetik Tuebingen RCV000513770 SCV000780455 uncertain significance not provided 2018-09-30 criteria provided, single submitter clinical testing
Center for Pediatric Genomic Medicine,Children's Mercy Hospital and Clinics RCV000513770 SCV000610377 uncertain significance not provided 2017-06-20 criteria provided, single submitter clinical testing
EGL Genetic Diagnostics,Eurofins Clinical Diagnostics RCV000513770 SCV000331577 uncertain significance not provided 2015-09-21 criteria provided, single submitter clinical testing
Genetic Services Laboratory, University of Chicago RCV000194652 SCV000248787 likely pathogenic Spastic ataxia Charlevoix-Saguenay type 2014-06-27 criteria provided, single submitter clinical testing
Invitae RCV000230214 SCV000289962 uncertain significance Spastic paraplegia 2018-12-20 criteria provided, single submitter clinical testing This sequence change replaces proline with glutamine at codon 2798 of the SACS protein (p.Pro2798Gln). The proline residue is moderately conserved and there is a moderate physicochemical difference between proline and glutamine. This variant is present in population databases (rs140551762, ExAC 0.3%). This variant has been reported in individuals affected with progressive myoclonus epilepsies (PMID: 25401298, 27433545) and with late-onset forms of autosomal recessive spastic ataxia of Charlevoix-Saguenay (PMID: 20876471). ClinVar contains an entry for this variant (Variation ID: 212115). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, this variant is a rare missense change with uncertain impact on protein function. It has been reported in both the population and affected individuals, but the available evidence is currently insufficient to determine its role in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Mayo Clinic Genetic Testing Laboratories,Mayo Clinic RCV000513770 SCV000802133 uncertain significance not provided 2016-03-11 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.